Search for: "SmithKline Beecham" Results 121 - 140 of 436
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2013, 6:56 am
Smithkline Beecham Corp., 2013 U.S. [read post]
17 Nov 2008, 4:38 pm
SmithKline Beecham Corp. d/b/a GlaxoSmithKline survived summary judgment in March when defendant GlaxoSmithKline argued that the doctrine of federal pre-emption precluded the plaintiffs from pursuing their state products liability claim. [read post]
7 Sep 2011, 4:30 am by Joshua Matz
SmithKline Beecham Corp.Docket: 11-204Issue(s): (1) Whether deference is owed to the Secretary of Labor's interpretation of the Fair Labor Standards Act's outside sales exemption and related regulations; and (2) whether the Fair Labor Standards Act's outside sales exemption applies to pharmaceutical sales representatives.Certiorari stage documents:Opinion below (9th Cir.)Petition for certiorari [read post]
1 Dec 2011, 10:10 am
SmithKline Beecham, to decide whether outside pharmaceutical reps are exempt from the overtime requirements of the FLSA. [read post]
4 Jan 2012, 6:49 am
SmithKline Beecham Corp, in which the court will decide the scope of the “outside sales” exemption under the Fair Labor... [read post]
6 Jun 2016, 1:08 pm by Lyle Denniston
The Court’s order sending the case of SmithKline Beecham Corp. v. [read post]
9 Sep 2008, 1:16 pm
A Philadelphia federal court has issued a decision that, in contrast to much recent jurisprudence, resolved FDA pre-emption issues favorably to tort plaintiffs. [read post]
20 Mar 2012, 8:36 am by Kedar
SmithKline Beecham Corp., which you can find here. [read post]
3 Nov 2012, 8:44 am by David Freedman
  Christopher regularly worked 60 hours per week, but received no overtime pay because SmithKline Beecham classified him as an “outside salesman. [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
19 Oct 2009, 5:53 pm
  It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and… [read post]
13 Nov 2009, 11:52 am
USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
2 Jul 2007, 2:51 pm
Teva Paxil CR: SmithKline Beecham v. [read post]